CRISPR Therapeutics (CRSP) PT Lowered to $150 at JMP Securities
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $53.55 -0.81%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JMP Securities analyst Silvan Tuerkcan lowered the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $150.00 (from $155.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
